AmbioPharm Inc.

AmbioPharm Inc. is a global custom synthetic peptide CDMO, founded in 2005 and headquartered in North Augusta, South Carolina, USA, specialising in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at clinical and commercial stages. At their manufacturing facilities in South Carolina, USA, and Shanghai, China, they produce New Chemical Entities (NCEs) under Current Good Manufacturing Practice (cGMP) for clients worldwide. The FDA and other global regulatory bodies have inspected both facilities multiple times, yielding excellent outcomes. Their mission is to accelerate clients' peptides to patients.

quick proposal

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.